FASTLANE study: Significantly higher proportion of pts w/early active axSpA on Tofa 5mg BID/naproxen achieved ASDAS inactive dse vs. PBO/naproxen at wk 16 (26.4% vs. 7% p0.006) AEs occured in 50% of pts on TOFA vs. 33% on PBO. AEs: infections, GI @RheumNow #ACR26 Abs2314 #ACRbest https://t.co/QkxaNCDQsu
